Theoretical foundations of mortality risk prediction scales for acute heart failure
DOI:
https://doi.org/10.56294/hl2024.431Keywords:
acute heart failure, prediction, mortality, cardiovascular diseases, scalesAbstract
Introduction: Heart failure is a public health problem. Multiple scales have been designed to predict mortality risk.
Objective: to systematize the theoretical references that support the mortality risk prediction scales due to acute heart failure
Development: different researchers approach the prediction process from different areas of knowledge, at the national and international level, and theoretical positions related to the topic are adopted.
Conclusions: the systematization carried out on the mortality prediction scales for acute heart failure allowed us to establish an approach to the theoretical references that support the topic.
References
1. Sinnenberg L, Givertz MM. Acute heart failure. Trends Cardiovasc Med. 2020 Feb 1 [cited 2022 Feb 14]; 30(2):104–12. Available from: https://pubmed.ncbi.nlm.nih.gov/31006522
2. Chávez-Alfonso Christian Osmar, Centurión Osmar Antonio. Mecanismos fisiopatológicos, neurohormonales y objetivos terapéuticos en la insuficiencia cardiaca aguda. Mem. Inst. investigando Cienc. Salud. 2019 Dic [citado 2023 Feb 02]; 17(3):82-96.Disponible en: https://doi.org/10.18004/mem.iics/9528/2019.017.03.82-096.
3. Mezquía PN, Soler MC, Tamargo BTO, Olmo MJ. Aplicación de un índice pronóstico de mortalidad en pacientes con insuficiencia cardiaca aguda. Rev Cubana Med.2016 Dic [citado 2022 Dic 29]; 55(4):287-296.Disponible en: http://scielo.sld.cu/scielo.php?Script=sci_arttext&pid=S0034-75232016000400003&Ing=es
4. Mezquía N., Soler C., Tamargo T., Olmo J. Valor de las variables clínicas para el pronóstico de la mortalidad por insuficiencia cardíaca aguda. Rev Cubana Med. 2015 Dic [citado 2024 Mar 3]; 54(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232015000400004&Ing=es.
5. Killip T, Kimball J. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol.1967 [cited 2023 june 20];20(4):457–64.
6. Araiza Garaygordobil D, Illescas González E, Cossío Aranda JE, Kuri Alfaro J, Guadalajara Boo JF. El valor clínico del examen físico en cardiología: revisión de la evidencia. Arch. Cardiol. Méx. 2017[citado 2019 mayo 9] ;87(4):265-269. DOI: 10.1016/j.acmx.2017.06.002
7. Wang Z, Dong Y, Gao PQ, Zhang QQ, Jiang H.El papel del índice de insuficiencia cardiaca aguda (AHFI) combinado con el grado de riesgo de mortalidad por insuficiencia cardiaca de emergencia (EHMRG) en la evaluación de los resultados clínicos y el pronóstico en pacientes con insuficiencia cardiaca aguda. Ley Cardiol.2022 ago [cited 2023 jun 20]; 77(6): 488-493.DOI:10.1080/00015385.2021.1955482
8. Fay MP, Li F. Causal interpretation of the hazard ratio in randomized Clinical trials. Clin Trials.2024 Apr 28 [cited 2024 jun 20]:17407745241243308.DOI: 10.1177/17407745241243308.
9. Verbeeck J, Saad ED. Rethinking survival analysis: advancing beyond the hazard ratio? Eur Heart J Acute Cardiovasc Care.2024 Mar 11[cited 2024 jun 20];13(3):313-315.doi: 10.1093/ehjacc/zuae017.PMID:38330167
10. Axelrod R, Nevo D. A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies.Biometric.2023 sep [cited 2024 jun 20];79(3)2743-2756.doi:10.1111/biom.13797.Epub 2022 Nov 29.
11. Kocaoglu S, Alatli T. The Efficiency of the HALP Score and the Modified HALP Score in Predicting Mortality in Patients with Acute Heart Failure Presenting to the Emergency Department. J Coll of Physician and surg Pak. 2022 jun [cited 2023 jun 20];32 (6):706-711.Available from: https://doi.org/10.29271/jcpsp.2022.06.706
12. Ning Y, Xiao H, Jinyu Y, Weibin S, Feng Q, Junqing H. La puntuación de hemoglobina, albumina, linfocitos y plaquetas y la proporción de neutrófilos a linfocitos son nuevos factores pronósticos significativos para los pacientes con cáncer de pulmón de células pequeñas que reciben quimioterapia. J Cáncer Res Ther.2020 [cited 2023 jun 20]; 16(5):1134-1139.Available from: http://doi.org/10.4103/jcrt.JCRT_1066_19
13. Zhang D, Zeng H, Pan Y, Zhao Y, Wang X, Chen J et al. Liver tumor markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for predicting Prognosis in ICC Patients after Surgery. J Pers Med.2022 [cited 2023 jun 20]; 12(12):2041. Available from: https://doi.org/10.3390/jpm12122041
14. Solmaz S, Uzun O, Sevindik OG, Demirkan F, Ozcan MA, Ozsan GH et al. The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma. Int j lab hematol.2023 feb [cited 2023 jun 20]; 45(1): 13-19.Available from: http://doi.org/10.1111/ijlh.13958
15. Nakada Y, Kawakami R, Matsushima S, Ide T, Kanaoka K, Ueda T et al. Simple Risk Score to Predict Survival in Acute Decompensated Heart Failure-A2B Score-. Circ J. 2019 [cited 2023 jun 20]; 83: 1019 – 1024.Disponible en : DOI: 10.1253/circj.CJ-18-1116
16. Kyodo A, Nakada Y, Nogi M, Ishihara S, Ueda T, Tohyama T et al. Evaluation of the A2B Score for prediction of survival in patients with Heart Failure in a Nationwide Cohort in Japan. J Am Heart Assoc.2024 Feb 20 [cited 2023 jun 20]; 13(4):e031104.DOI:10.1161/JAHA.123.031104.
17. Ma J, Hu S, Hsieh M, Lee Y, Huang S, Chen K et al. PEAL Score to Predict the Mortality Risk of Cardiogenic Shock in the Emergency Department: An Observational Study. J. Pers. Med. 2023; 13: 1614.https://doi.org/10.3390/jpm13111614
18. Liu L, Gong B, Wang W, Xu K, Wang K and Song G. Association between haemoglobin, albumin, lymphocytes, and platelets and mortality in patients with heart failure. ESC Heart Fail. 2024 Apr;11(2): 1051–1060.DOI: 10.1002/ehf2.14662
19. Busch JM, Arnold I, Kellett J, Brabrand M, Bingisser R, Nickel CH.Validation of a Simple Score for Mortality Prediction in a Cohort of Unselected Emergency Patients. Int J Clin Pract.2022 [cited 2023 jun 20];5:1-9.Disponible en https://doi.org/10.1155/2022/7281693
20. Chuda A, Banach M, Maciejewski M, Bielecka-Dabrowa A. Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice. Ir J Med Sci.2022 [cited 2023 jun 20]; 191(1):213–227. Disponible en https://doi.org/10.1007/s11845-020-02477-z
21. Angkananard T, Inthanoo T, Sricholwattana S, Rattanajaruskul N, Wongsoasu A, Roongsangmanoon, W. The predictive role of Neutrophil-to-Lymphocyte Ratio (NLR) and Mean Platelet Volume-to-Lymphocyte Ratio (MPVLR) for Cardiovascular Events in Adult Patients with Acute heart Failure. Mediators of inflammation.2021 [cited 2023 may 30];2021:12.Disponible en https://doi.org/10.1155/2021/6889733
22. Stiell Ian G., Clement Catherine M., Perry Jeffrey J., Eagles Debra, McRae Andrew D., Yan Justin W.The HEARTRISK6 Scale Predicting Short-Term Serious Outcomes in Emergency Department Acute Heart Failure Patients. JACC: Advances [Internet]. 2024 [citado 2024 nov 23]; 3(7). Disponible en: https://doi.org/10.1016/j.jacadv.024.100988
23. Miró Ò, Rossello X, Gil V, Martín-Sánchez FJ, Llorens P, Herrero-Puente P et al. Analysis of How Emergency Physicians' Decisions to Hospitalize or Discharge Patients With Acute Heart Failure Match the Clinical Risk Categories of the MEESSI-AHF Scale. Ann Emerg Med. 2019 Aug [cited 2023 jun 20]; 74(2):204-215.DOI:10.1016/j.annemergmed.2019.03.010
24. Lee DS, Lee JS, Schull MJ, Borgundvaag B, Edmonds ML, Ivankovic M et al. Prospective Validation of the Emergency Heart Failure Mortality Risk Grade for Acute Heart Failure. Circulation. 2019 Feb 26 [cited 2023 jun 20]; 139 (9):1146-1156. DOI: 10.1161/CIRCULACIÓNAHA.118.035509
25. Rider I, Sorense M, Brady WJ, Gottlieb M, Benson S, Koyfman A et al. Disposition of acute decompensated heart failure from the emergency department: An evidence-based review. The American Journal of emergency medicine.2021 [cited 2023 jun 3];50: 459-465.Disponible en https://doi.org/10.1016/j.ajem.2021.08.070
Published
Issue
Section
License
Copyright (c) 2024 Lucia Nivia Turro Mesa, Germán Del Río Caballero, Niger Guzmán Pérez, German Ricardo del Río Mesa, Rita María Mesa Valiente, Margarita Montes de Oca Carmenaty (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
